To subscribe:
To have your comment included in a future podcast, call 617-440-4374. Please leave your name, number, and the podcast ID number.
(3 votes, average: 2.00 out of 5)We talk with three of the academic authors of a New England Journal of Medicine study that pooled data from a few studies in an attempt to examine the possible link between use of bisphosphonates and femoral-shaft fractures. Interview-related links: Physician’s First Watch coverage NEJM paper NEJM editorial FDA statement News-related links: Aspirin ineffective in [...]
(5 votes, average: 4.80 out of 5)Patients who consult urologists only are more likely to get radical prostatectomy, and those who consult both urologists and radiation oncologists are more likely to get radiation. Those who see internists are more likely to receive watchful waiting. What are all these facts trying to tell us? Our conversation is with the principal authors of [...]
(3 votes, average: 3.33 out of 5)This week, a conversation with Michael Hochman on his examination of what the major general journals publish in the way of comparative effectiveness studies. He talks about what they are and how to think about that reprint that the drug rep has just dropped off for you. Reach us at 617-440-4374, or write to jelia@jwatch.org. [...]
(2 votes, average: 2.00 out of 5)Our attempts to get an interview with a researcher were unavailing, so we’ve gone to plan B and repeat a useful look at treating community-acquired pneumonia according to guideline recommendations. Please leave comments and complaints at jelia@jwatch.org. You can call and voice these at 1-617-440-4374. Interview-related links: Community-Acquired Pneumonia: Guideline-Compliant Treatment Is Better IDSA/ATS guidelines [...]
